title: Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
abstract: It is well established that incompatible HLA antigens presented by donor tissue readily evoke an immune response. Prospective HLA matching policies, widespread in European kidney transplant centers have reduced the level of HLA mismatching and have significantly improved graft survival. The influence of HLA incompatibility in heart transplantation remains controversial, and prospective HLA matching is seldom achieved. We examined the role of HLA antigen mismatching on transplant rejection by analyzing 2569 endomyocardial biopsies (EMB) from 157 consecutive orthotopic heart transplants performed from April 1987 to August 1993 in our own center. Biopsies were graded according to the accepted International Classification, with grade 2 and higher indicating rejection. Among 91 patients who received a 2 HLA-DR mismatch transplant 34% of 1624 biopsies analyzed were graded as > or = 2. This frequency fell to 29% of 797 biopsies for 53 patients with a one-HLA-DR mismatch and to 18% of 148 biopsies for 13 patients in the zero-HLA-DR-mismatch group (P < 0.00005). No significant effect on EMB grade frequencies was observed using the same method of analysis with transplants mismatched at the HLA-A or HLA-B loci apart from analysis of HLA-B matched transplants at 3 months posttransplant (P = 0.02). The close linkage of the HLA-B and HLA-DR loci may account for this observation. The results of this study show that heart transplants matched at the HLA-DR locus have a significantly reduced incidence of EMB grades indicative of rejection requiring augmented immunosuppressive therapy. We propose that prospective HLA-DR matching should be adopted for allocation of donor hearts for more efficient use of this precious and limited resource.
authors.affiliation: North Western Regional Tissue Typing Laboratory, St. Mary's Hospital, Manchester, United Kingdom.
authors.forename: S
authors.initials: S
authors.lastname: Sheldon
authors.forename: P S
authors.initials: PS
authors.lastname: Hasleton
authors.forename: N A
authors.initials: NA
authors.lastname: Yonan
authors.forename: A N
authors.initials: AN
authors.lastname: Rhaman
authors.forename: A K
authors.initials: AK
authors.lastname: Deiraniya
authors.forename: C S
authors.initials: CS
authors.lastname: Campbell
authors.forename: N H
authors.initials: NH
authors.lastname: Brooks
authors.forename: P A
authors.initials: PA
authors.lastname: Dyer
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D004699:Endocardium / Q000276:immunology / Q000473:pathology; D006084:Graft Rejection / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D006085:Graft Survival; D006684:HLA-DR Antigens / Q000032:analysis* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006650:Histocompatibility Testing; D006801:Humans; D008875:Middle Aged; D009206:Myocardium / Q000276:immunology / Q000473:pathology
chemical_list: D006684:HLA-DR Antigens